title: Expression profiling of PPARγ-regulated microRNAs in human subcutaneous and visceral adipogenesis in both genders.
abstract: Clinical evidence shows that visceral fat accumulation decreases whereas sc fat increases in patients treated with thiazolidinediones (TZDs), a type of peroxisome proliferator-activated receptor (PPAR)γ agonist. To clarify the molecular mechanism of the differential effects of PPARγ agonists on sc and visceral adipose, we investigated expression profiling of PPARγ-regulated micro-RNAs (miRNAs) using miRNA microarray. The level of 182 miRNAs changed in human sc adipose treated with pioglitazone, whereas only 46 miRNAs changed in visceral adipose. Among these miRNAs, 27 miRNAs changed in both human sc and visceral adipocytes. Specifically, 7 miRNAs changed at the same direction in sc and visceral adipocytes, whereas 20 miRNAs changed at opposite directions in these two fat depots. Bioinformatics analysis showed that these miRNAs and the predicted target genes were involved in TGF-β-, Wnt/β-catenin-, and insulin-signaling pathways and related to metabolic regulation or cell cycle. Among the miRNAs changed at the same direction in sc and visceral adipocytes, miR-378, located in the first intron of PPARγ coactivator 1β (PGC1β), was coordinately expressed with PGC1β during adipogenesis. Moreover, miR-378 and PGC1β were both up-regulated by PPARγ agonist. We also provided evidence that miR-378 promoted adipogenesis in sc fat, but not in visceral fat. These results display miRNAs expression profiling altered in sc and visceral adipogenesis regulated by PPARγ and suggest a potential mechanism underlying the differential effects of TZDs on the 2 fat depot accumulations.
authors.affiliation: Department of Geratology (J.Y., X.K., J.L., Y.L., Y.S., S.L., W.D., C.W., G.D.) and Department of General Surgery (F.Z.), the First Hospital Affiliated to Nanjing Medical University, Nanjing, People's Republic of China.
authors.forename: Jing
authors.initials: J
authors.lastname: Yu
authors.forename: Xiaocen
authors.initials: X
authors.lastname: Kong
authors.forename: Juan
authors.initials: J
authors.lastname: Liu
authors.forename: Yifan
authors.initials: Y
authors.lastname: Lv
authors.forename: Yunlu
authors.initials: Y
authors.lastname: Sheng
authors.forename: Shan
authors.initials: S
authors.lastname: Lv
authors.forename: Wenjuan
authors.initials: W
authors.lastname: Di
authors.forename: Chen
authors.initials: C
authors.lastname: Wang
authors.forename: Feng
authors.initials: F
authors.lastname: Zhang
authors.forename: Guoxian
authors.initials: G
authors.lastname: Ding
mesh_terms: D017667:Adipocytes / Q000166:cytology / Q000378:metabolism; D050156:Adipogenesis / Q000187:drug effects / Q000235:genetics*; D002478:Cells, Cultured; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D050152:Intra-Abdominal Fat / Q000166:cytology / Q000378:metabolism*; D008297:Male; D035683:MicroRNAs / Q000235:genetics*; D047495:PPAR gamma / Q000819:agonists / Q000378:metabolism*; D050151:Subcutaneous Fat / Q000166:cytology / Q000378:metabolism*; D045162:Thiazolidinediones / Q000494:pharmacology; D059467:Transcriptome
chemical_list: D035683:MicroRNAs; D047495:PPAR gamma; D045162:Thiazolidinediones